Wockhardt, the established pharmaceutical company, is currently undergoing a transformation that could result in new ownership. The company's future is up in the air, with numerous potential investors reportedly showing interest. This change comes after a period of obstacles for Wockhardt, which has faced regulatory issues in recent years. Renowne